Genomic characterization of novel Neisseria species.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 09 2019
Historique:
received: 06 02 2019
accepted: 04 09 2019
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 30 10 2020
Statut: epublish

Résumé

Of the ten human-restricted Neisseria species two, Neisseria meningitidis, and Neisseria gonorrhoeae, cause invasive disease: the other eight are carried asymptomatically in the pharynx, possibly modulating meningococcal and gonococcal infections. Consequently, characterizing their diversity is important for understanding the microbiome in health and disease. Whole genome sequences from 181 Neisseria isolates were examined, including those of three well-defined species (N. meningitidis; N. gonorrhoeae; and Neisseria polysaccharea) and genomes of isolates unassigned to any species (Nspp). Sequence analysis of ribosomal genes, and a set of core (cgMLST) genes were used to infer phylogenetic relationships. Average Nucleotide Identity (ANI) and phenotypic data were used to define species clusters, and morphological and metabolic differences among them. Phylogenetic analyses identified two polyphyletic clusters (N. polysaccharea and Nspp.), while, cgMLST data grouped Nspp isolates into nine clusters and identified at least three N. polysaccharea clusters. ANI results classified Nspp into seven putative species, and also indicated at least three putative N. polysaccharea species. Electron microscopy identified morphological differences among these species. This genomic approach provided a consistent methodology for species characterization using distinct phylogenetic clusters. Seven putative novel Neisseria species were identified, confirming the importance of genomic studies in the characterization of the genus Neisseria.

Identifiants

pubmed: 31551478
doi: 10.1038/s41598-019-50203-2
pii: 10.1038/s41598-019-50203-2
pmc: PMC6760525
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13742

Subventions

Organisme : Medical Research Council
ID : MR/P008852/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 087622/Z/08/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103957/Z/14/Z
Pays : United Kingdom

Références

Microbiology (Reading). 2005 Jul;151(Pt 7):2141-2150
pubmed: 16000705
J Infect. 2016 Jun;72(6):667-677
pubmed: 27018131
Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91
pubmed: 17220447
BMC Biol. 2007 Sep 07;5:35
pubmed: 17825091
Lancet. 2000 Sep 23;356(9235):1078
pubmed: 11009146
Clin Microbiol Rev. 2011 Jul;24(3):447-58
pubmed: 21734242
BMC Bioinformatics. 2011 Apr 28;12:124
pubmed: 21526987
Lancet Infect Dis. 2015 Dec;15(12):1420-8
pubmed: 26515523
Philos Trans R Soc Lond B Biol Sci. 2006 Nov 29;361(1475):1899-909
pubmed: 17062409
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5
pubmed: 9501229
Epidemiol Infect. 1987 Dec;99(3):591-601
pubmed: 3123263
J Allergy Clin Immunol. 2010 Jan;125(1):203-8
pubmed: 19944455
J Clin Microbiol. 2012 Dec;50(12):4020-7
pubmed: 23035186
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Science. 2010 Apr 23;328(5977):508-12
pubmed: 20413503
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
BMC Biol. 2005 Mar 07;3:6
pubmed: 15752428
Infect Immun. 1992 Dec;60(12):5267-82
pubmed: 1452360
J Dent Res. 2008 Nov;87(11):1016-20
pubmed: 18946007
Clin Infect Dis. 2011 Jan 1;52(1):70-7
pubmed: 21148522
J Infect Dis. 1978 Feb;137(2):112-21
pubmed: 415097
J Clin Microbiol. 2014 May;52(5):1375-81
pubmed: 24523465
Microbiology (Reading). 2012 Jun;158(Pt 6):1570-1580
pubmed: 22422752
ISME J. 2016 Jan;10(1):97-108
pubmed: 26151645
Microbiology (Reading). 2012 Apr;158(Pt 4):1005-1015
pubmed: 22282518
Annu Rev Microbiol. 2002;56:457-87
pubmed: 12142474
Genome Res. 2008 May;18(5):821-9
pubmed: 18349386
J Bacteriol. 2012 Sep;194(17):4709-17
pubmed: 22753064
BMC Genomics. 2010 Nov 23;11:652
pubmed: 21092259
Infect Immun. 2005 Apr;73(4):2424-32
pubmed: 15784588
Int J Syst Evol Microbiol. 2013 Oct;63(Pt 10):3920-3926
pubmed: 24097834
Microbiology (Reading). 2015 Jul;161(7):1297-1312
pubmed: 25814039
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
Curr Opin Pulm Med. 2016 Nov;22(6):623-8
pubmed: 27583669
BMC Genomics. 2014 Dec 18;15:1138
pubmed: 25523208
Methods Mol Biol. 2007;369:449-66
pubmed: 17656764
Trop Med Int Health. 2013 Aug;18(8):968-78
pubmed: 23682910
Eur J Clin Microbiol. 1985 Aug;4(4):431-3
pubmed: 4043067
J Bacteriol. 2005 Sep;187(18):6255-7
pubmed: 16159756
Clin Infect Dis. 2015 May 15;60(10):1512-20
pubmed: 25814628
Int J Syst Evol Microbiol. 2017 Nov;67(11):4304-4310
pubmed: 28933320
Curr Opin Biotechnol. 1997 Jun;8(3):340-5
pubmed: 9206017
Int J Syst Evol Microbiol. 2010 Jan;60(Pt 1):249-266
pubmed: 19700448
Nat Rev Microbiol. 2005 Sep;3(9):733-9
pubmed: 16138101
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Lancet. 2002 May 25;359(9320):1829-31
pubmed: 12044380
Clin Vaccine Immunol. 2009 Aug;16(8):1113-20
pubmed: 19553555
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2567-72
pubmed: 15701695

Auteurs

Kanny Diallo (K)

Centre pour les Vaccins en Développement, Bamako, Mali. kanny.diallo@zoo.ox.ac.uk.
Department of Zoology, University of Oxford, Oxford, UK. kanny.diallo@zoo.ox.ac.uk.

Jenny MacLennan (J)

Department of Zoology, University of Oxford, Oxford, UK.

Odile B Harrison (OB)

Department of Zoology, University of Oxford, Oxford, UK.

Chisomo Msefula (C)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.

Samba O Sow (SO)

Centre pour les Vaccins en Développement, Bamako, Mali.

Doumagoum M Daugla (DM)

Centre de Support en Santé International, N'Djamena, Chad.

Errin Johnson (E)

Electron Microscopy Facility, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Caroline Trotter (C)

Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.

Calman A MacLennan (CA)

Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Julian Parkhill (J)

Wellcome Trust Sanger Institute, Cambridge, UK.

Ray Borrow (R)

Vaccine Evaluation Unit, Public Health England, Manchester, UK.

Brian M Greenwood (BM)

London School of Hygiene & Tropical Medicine, London, UK.

Martin C J Maiden (MCJ)

Department of Zoology, University of Oxford, Oxford, UK. martin.maiden@zoo.ox.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH